Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study.
Conte PF, Donati S, Gennari A, Guarneri V, Orlandini C, Rondini M, Roncella M, Marini L, Collecchi P, Viacava P, Naccarato AG, Degli Esposti R, Bonardi S, Bottini A, Saracchini S, Tumolo S, Gullo G, Santoro A, Crino L.
Conte PF, et al. Among authors: roncella m.
Br J Cancer. 2005 Aug 22;93(4):406-11. doi: 10.1038/sj.bjc.6602723.
Br J Cancer. 2005.
PMID: 16052214
Free PMC article.
Clinical Trial.